Respiratory muscle weakness in peripheral neuropathies

Journal of the Peripheral Nervous System

Volumn 15, Issue 4, 2010, Pages 307-313

  Burakgazi, Ahmet Z ^a   Höke, Ahmet ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CIDP; CMT; Diaphragm weakness; GBS; MMN; peripheral neuropathy; Respiratory insufficiency

Indexed keywords

IMMUNOGLOBULIN G;

ARTIFICIAL VENTILATION; BREATHING MUSCLE; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; GUILLAIN BARRE SYNDROME; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPOXEMIA; MOTOR NEUROPATHY; MUSCLE WEAKNESS; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SPEECH DISORDER; TACHYCARDIA; TACHYPNEA; TRACHEOSTOMY; VITAL CAPACITY;

ANIMALS; HUMANS; MUSCLE WEAKNESS; PERIPHERAL NERVOUS SYSTEM DISEASES; RESPIRATORY MUSCLES;

EID: 78650837411     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2010.00293.x     Document Type: Review

References (63)

1. Asahina M, Kuwabara S, Hattori T, Katayama K, (2000). Respiratory insufficiency in a patient with hereditary neuropathy with liability to pressure palsy. J Neurol Neurosurg Psychiatry 68: 110-111.
2. Banchs I, Casasnovas C, Alberti A, De Jorge L, Povedano M, Montero J, Martinez-Matos JA, Volpini V, (2009). Diagnosis of Charcot-Marie-Tooth disease. J Biomed Biotechnol 2009: 985415.
3. Berciano J, Combarros O, (2003). Hereditary neuropathies. Curr Opin Neurol 16: 613-622.
4. Beydoun SR, Copeland D, (2000). Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block. Muscle Nerve 23: 556-559.
5. Bird TD, Ott J, Giblett ER, (1982). Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome'1. Am J Hum Genet 34: 388-394.
6. Bjartmar C, Wujek JR, Trapp BD, (2003). Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206: 165-171.
7. Bolino A, Levy ER, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM, Christodoulou RK, Hausmanowa-Petrusewicz I, Mandich P, Gambardella A, Quattrone A, Devoto M, Monaco AP, (2000a). Genetic refinement and physical mapping of the CMT4B gene on chromosome 11q22. Genomics 63: 271-278.
8. Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM, Christodoulou K, Hausmanowa-Petrusewicz I, Mandich P, Schenone A, Gambardella A, Bono F, Quattrone A, Devoto M, Monaco AP, (2000b). Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25: 17-19.
9. Chan CK, Mohsenin V, Loke J, Virgulto J, Sipski ML, Ferranti R, (1987). Diaphragmatic dysfunction in siblings with hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease). Chest 91: 567-570.
10. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD, (1993). DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72: 143-151.
11. Cheng Q, Jiang GX, Press R, Andersson M, Ekstedt B, Vrethem M, Liedholm LJ, Lindsten H, Brattstrom L, Fredrikson S, Link H, de Pedro-Cuesta J, (2000). Clinical epidemiology of Guillain-Barre syndrome in adults in Sweden 1996-97: a prospective study. Eur J Neurol 7: 685-692.
12. Deng HX, Klein CJ, Yan J, Shi Y, Wu Y, Fecto F, Yau HJ, Yang Y, Zhai H, Siddique N, Hedley-Whyte ET, Delong R, Martina M, Dyck PJ, Siddique T, (2010). Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet 42: 165-169.
13. Durand MC, Prigent H, Sivadon-Tardy V, Orlikowski D, Caudie C, Devaux C, Clair B, Gaillard JL, Lofaso F, Raphael JC, Sharshar T, (2005). Significance of phrenic nerve electrophysiological abnormalities in Guillain-Barre syndrome. Neurology 65: 1646-1649.
14. Dyck PJ, Lambert EH, (1968a). Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 18: 603-618.
15. Dyck PJ, Lambert EH, (1968b). Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 18: 619-625.
16. Dyck PJ, Chance P, Lebo R, (1993). Hereditary motor and sensory neuropathies. In: Peripheral Neuropathy., Dyck PJ, (Ed). WB Saunders, Philadelphia, pp 1094-1136.
17. Dyck PJ, Litchy WJ, Minnerath S, Bird TD, Chance PF, Schaid DJ, Aronson AE, (1994). Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 35: 608-615.
18. Emery AE, (1991). Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord 1: 19-29.
19. French Cooperative Group on Plasma Exchange in Guillain-Barre syndrome (1987). Efficiency of plasma exchange in Guillain-Barre syndrome: role of replacement fluids. Ann Neurol 22: 753-761.
20. Gilchrist D, Chan CK, Deck JH, (1989). Phrenic involvement in Charcot-Marie-Tooth disease. A pathologic documentation. Chest 96: 1197-1199.
21. Gorson KC, Allam G, Ropper AH, (1997). Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48: 321-328.
22. Guillain-Barré Syndrome Steroid Trial Group (1993). Double-blind trial of intravenous methylprednisolone in Guillain-Barre syndrome. Lancet 341: 586-590.
23. Hardie R, Harding AE, Hirsch N, Gelder C, Macrae AD, Thomas PK, (1990). Diaphragmatic weakness in hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 53: 348-350.
24. Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, Ohnishi A, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Nakashima K, Kira J, Kaji R, Oka N, Sobue G, (2003). Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain 126: 134-151.
25. Henderson RD, Lawn ND, Fletcher DD, McClelland RL, Wijdicks EF, (2003). The morbidity of Guillain-Barre syndrome admitted to the intensive care unit. Neurology 60: 17-21.
26. Henderson RD, Sandroni P, Wijdicks EF, (2005). Chronic inflammatory demyelinating polyneuropathy and respiratory failure. J Neurol 252: 1235-1237.
27. Hughes R, Sanders E, Hall S, Atkinson P, Colchester A, Payan P, (1992). Subacute idiopathic demyelinating polyradiculoneuropathy. Arch Neurol 49: 612-616.
28. Kabitz HJ, Sonntag F, Walker D, Schwoerer A, Walterspacher S, Kaufmann S, Beuschlein F, Seufert J, Windisch W, (2008). Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetes. Diabetologia 51: 191-197.
29. Kijima K, Numakura C, Izumino H, Umetsu K, Nezu A, Shiiki T, Ogawa M, Ishizaki Y, Kitamura T, Shozawa Y, Hayasaka K, (2005). Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum Genet 116: 23-27.
30. Krajewski K, Turansky C, Lewis R, Garbern J, Hinderer S, Kamholz J, Shy ME, (1999). Correlation between weakness and axonal loss in patients with CMT1A. Ann N Y Acad Sci 883: 490-492.
31. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME, (2000). Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123: 1516-1527.
32. Landoure G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Inada H, Shi Y, Taye AA, Kong L, Munns CH, Choo SS, Phelps CB, Paudel R, Houlden H, Ludlow CL, Caterina MJ, Gaudet R, Kleta R, Fischbeck KH, Sumner CJ, (2010). Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet 42: 170-174.
33. Laroche CM, Carroll N, Moxham J, Stanley NN, Evans RJ, Green M, (1988). Diaphragm weakness in Charcot-Marie-Tooth disease. Thorax 43: 478-479.
34. Lawn ND, Wijdicks EF, (1999). Tracheostomy in Guillain-Barre syndrome. Muscle Nerve 22: 1058-1062.
35. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF, (2001). Anticipating mechanical ventilation in Guillain-Barre syndrome. Arch Neurol 58: 893-898.
36. Li J, Krajewski K, Lewis RA, Shy ME, (2004). Loss-of-function phenotype of hereditary neuropathy with liability to pressure palsies. Muscle Nerve 29: 205-210.
37. Macia F, Le Masson G, Rouanet-Larriviere M, Habonimana D, Ferrer X, Marthan R, Lagueny A, (2003). A prospective evaluation of phrenic nerve conduction in multifocal motor neuropathy and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 28: 319-323.
38. Markand ON, Kincaid JC, Pourmand RA, Moorthy SS, King RD, Mahomed Y, Brown JW, (1984). Electrophysiologic evaluation of diaphragm by transcutaneous phrenic nerve stimulation. Neurology 34: 604-614.
39. Martyn CN, Hughes RA, (1997). Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 62: 310-318.
40. Matsuyama H, Haymaker W, (1967). Distribution of lesions in the Landry-Guillain-Barre syndrome, with emphasis on involvement of the sympathetic system. Acta Neuropathol 8: 230-241.
41. Nathanson BN, Yu DG, Chan CK, (1989). Respiratory muscle weakness in Charcot-Marie-Tooth disease. A field study. Arch Intern Med 149: 1389-1391.
42. Orlikowski D, Prigent H, Sharshar T, Lofaso F, Raphael JC, (2004). Respiratory dysfunction in Guillain-Barre Syndrome. Neurocrit Care 1: 415-422.
43. Parman Y, (2007). Hereditary neuropathies. Curr Opin Neurol 20: 542-547.
44. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group (1997). Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Lancet 349: 225-230.
45. Plummer AL, Gracey DR, (1989). Consensus conference on artificial airways in patients receiving mechanical ventilation. Chest 96: 178-180.
46. Raphael JC, Chevret S, Hughes RA, Annane D, (2001). Plasma exchange for Guillain-Barre syndrome. Cochrane Database Syst Rev 2: CD001798.
47. Rees JH, Thompson RD, Smeeton NC, Hughes RA, (1998). Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry 64: 74-77.
48. Ropper AH, Kehne SM, (1985). Guillain-Barre syndrome: management of respiratory failure. Neurology 35: 1662-1665.
49. Sadiq SA, Thomas FP, Kilidireas K, Protopsaltis S, Hays AP, Lee KW, Romas SN, Kumar N, van den Berg L, Santoro M, et al. (1990). The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 40: 1067-1072.
50. Sagliocco L, Orlandi G, Calabrese R, Pellegrinetti A, Baglini O, Castelli F, Baldinotti F, Sartucci F, (2003). Electrodiagnostic evidence of phrenic nerve demyelination in Charcot-Marie-Tooth disease 1A. Am J Phys Med Rehabil 82: 754-759.
51. Sasaki M, Ohara S, Oide T, Hayashida K, Hayashi R, (2004). An autopsy case of chronic inflammatory demyelinating polyradiculoneuropathy with respiratory failure. Muscle Nerve 30: 382-387.
52. Sharshar T, Chevret S, Bourdain F, Raphael JC, (2003). Early predictors of mechanical ventilation in Guillain-Barre syndrome. Crit Care Med 31: 278-283. (Pubitemid 36151185)
53. Tang EW, Jardine DL, Rodins K, Evans J, (2003). Respiratory failure secondary to diabetic neuropathy affecting the phrenic nerve. Diabet Med 20: 599-601.
54. The French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome (1997). Appropriate number of plasma exchanges in Guillain-Barre syndrome. Ann Neurol 41: 298-306.
55. The Guillain-Barré syndrome Study Group (1985). Plasmapheresis and acute Guillain-Barré syndrome. Neurology 35: 1096-1104.
56. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L, (1998). Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278-285.
57. Verny C, Ravise N, Leutenegger AL, Pouplard F, Dubourg O, Tardieu S, Dubas F, Brice A, Genin E, LeGuern E, (2004). Coincidence of two genetic forms of Charcot-Marie-Tooth disease in a single family. Neurology 63: 1527-1529.
58. Wanke T, Paternostro-Sluga T, Grisold W, Formanek D, Auinger M, Zwick H, Irsigler K, (1992). Phrenic nerve function in type 1 diabetic patients with diaphragm weakness and peripheral neuropathy. Respiration 59: 233-237.
59. White JE, Bullock RE, Hudgson P, Home PD, Gibson GJ, (1992). Phrenic neuropathy in association with diabetes. Diabet Med 9: 954-956.
60. Wijdicks EF, Borel CO, (1998). Respiratory management in acute neurologic illness. Neurology 50: 11-20.
61. Winer JB, Hughes RA, Osmond C, (1988). A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 51: 605-612.
62. Wolf E, Shochina M, Fidel Y, Gonen B, (1983). Phrenic neuropathy in patients with diabetes mellitus. Electromyogr Clin Neurophysiol 23: 523-530.
63. Zifko U, Chen R, Remtulla H, Hahn AF, Koopman W, Bolton CF, (1996). Respiratory electrophysiological studies in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 60: 191-194.